Oramed Pharmaceuticals
ORMP
#9091
Rank
NZ$0.20 B
Marketcap
NZ$5.22
Share price
4.66%
Change (1 day)
22.96%
Change (1 year)

Oramed Pharmaceuticals (ORMP) - Cash on Hand

Cash on Hand as of June 2025 : NZ$0.16 Billion

According to Oramed Pharmaceuticals's latest financial reports the company has NZ$0.16 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Oramed Pharmaceuticals - Cash on Hand chart (from 2006 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31NZ$0.25 B-1.79%
2023-12-31NZ$0.25 B4.47%
2022-12-31NZ$0.24 B
2021-08-31NZ$0.13 B125.26%
2020-08-31NZ$59.26 M15.89%
2019-08-31NZ$51.13 M11.02%
2018-08-31NZ$46.06 M64.33%
2017-08-31NZ$28.02 M-34.52%
2016-08-31NZ$42.8 M57.84%
2015-08-31NZ$27.12 M6.43%
2014-08-31NZ$25.48 M132.65%
2013-08-31NZ$10.95 M71.93%
2012-08-31NZ$6.37 M186.25%
2011-08-31NZ$2.22 M29.88%
2010-08-31NZ$1.71 M-57.39%
2009-08-31NZ$4.02 M-44.18%
2008-08-31NZ$7.2 M164.64%
2007-08-31NZ$2.72 M913.44%
2006-08-31NZ$0.26 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Ultragenyx Pharmaceutical
RARE
NZ$0.73 B 334.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
NZ$8.81 B 5,131.25%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
NZ$17.97 B 10,571.74%๐Ÿ‡ซ๐Ÿ‡ท France
Compugen
CGEN
NZ$0.14 B-12.10%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Lexicon Pharmaceuticals
LXRX
NZ$0.19 B 18.39%๐Ÿ‡บ๐Ÿ‡ธ USA